World News: 12:33 GMT Tuesday 14th January 2020. [Research and Markets via Globe Newswire via SPi World News]
Dublin, Jan. 14, 2020 (GLOBE NEWSWIRE) -- The report has been added to offering.The global women health diagnostics market is significantly growing during the forecast period.
The key factors that are contributing towards the growth of the global women health diagnostic market are increasing incidences of lifestyle-related and chronic disorders in women, rise in the number of imaging centers and private diagnostics, rising prevalence of infectious diseases, and growing adoption of point of care and rapid diagnostic tests.According to the World Health Organization (WHO), around 36.9 million people across the globe are living with HIV and nearly 23.3 million people have received antiretroviral treatment in 2018. Furthermore, increasing incidences of chronic disorders such as breast cancer have raised the need for health diagnostics in women.Breast cancer is one of the most common cancer types among women at the global level. As per Breast Cancer Research Foundation, in 2018, the breast cancer represents one in four of all cancers in women across the globe; whereas, nearly one in eight women in the US are expected to develop invasive breast cancer during the course of her lifetime.According to the American Cancer Society, in 2019, around 268,600 new cases of invasive breast cancer are projected to be diagnosed in women in the US. Such occurrence widens the scope for the growth of global women health diagnostics market. Apart from it, supportive initiatives by government and health organizations and rising awareness about fertility tests have also played a vital role in the growth of the global market.However, lack of skilled laboratory personnel and high cost of procedures and diagnostic imaging systems are the key factors restraining the growth of the market.The global women health diagnostics market is segmented based on application and end-user. Based on applications, the prenatal testing is expected to hold a major share due to the owing to rising prevalence of prenatal diseases, surging healthcare expenditure, and increasing maternal age. Based on end-user, the diagnostic centers and hospitals accounted for a major share in the market due to the high number of visits to hospitals.Geographically, the global women health diagnostics market is segmented into North America, Europe, Asia-Pacific, and Rest of the World. North America contributes a significant share in the global women health diagnostics market due to increasing demand for fertility testing monitors, rising prevalence of cancer, and incidences of lifestyle-related disorders within the region. Furthermore, Asia-Pacific is expected to witness a considerable growth rate in the global women health diagnostics market during the forecast period. The growth is accredited to the rising awareness among women related to several health disorders and increases proportionately income.The key players operating in the global women health diagnostics market include Abbott Laboratories, Inc., biomerieux SA, Becton, Dickson and Co., DIALAB Gmbh, F. Hoffmann-La Roche Ltd., Fujifilm Holdings Corp., Siemens AG, Quest Diagnostics Inc., and General Electric Co. Adoption of growth strategies such as mergers and acquisitions, product launch, partnership, and agreements are the key strategies of major market players.For instance, in January 2017, Abbott Laboratories, Inc. launched a biomedical immunization machine such as Alinityci-series diagnostic systems. The Alinityci-series is easy to use due to the compact size and scalable systems to maximize efficiency and throughput. It enables hospitals and labs to achieve better healthcare performance. 1.1. Research Methods and Tools1.2. Market Breakdown1.2.1. By Segments1.2.2. By Geography1.2.3. By Stakeholders2.1. Scope of the Report2.2. Analyst Insight & Current Market Trends2.2.1. Key Findings2.2.2. Recommendations2.2.3. Conclusion2.3. Rules & Regulations3.1. Company Share Analysis3.2. Key Strategy Analysis3.3. Key Company Analysis3.3.1. General Electric Co.3.3.2. Abbott Laboratories, Inc.3.3.3. Siemens AG3.3.4. Becton, Dickinson and Co.3.3.5. Quest Diagnostics Inc.4.1 Motivators4.2 Restraints4.3 Opportunities 5.1. Global Women Health Diagnostics Market by Application5.1.1. Breast Cancer Testing5.1.2. Cervical Cancer Testing5.1.3. Pregnancy & Fertility Testing5.1.4. Ovarian Cancer Testing5.1.5. Infectious Disease Testing5.1.6. Ultrasound Tests 5.1.7. Sexually Transmitted Disease Testing5.1.8. Others (Osteoporosis Testing and Prenatal Genetic Testing)5.2. Global Women Health Diagnostics Market by End-User5.2.1. Diagnostic and Imaging Centers5.2.2. Hospitals and Clinics5.2.3. Home Care6.1. North America6.1.1. United States6.1.2. Canada6.2. Europe6.2.1. UK6.2.2. Germany6.2.3. Italy6.2.4. Spain6.2.5. France6.2.6. Rest of Europe6.3. Asia-Pacific6.3.1. China6.3.2. India6.3.3. Japan6.3.4. Rest of Asia-Pacific6.4. Rest of the World7.1. Abbott Laboratories, Inc.7.2. Becton, Dickson and Co.7.3. bioMerieux S.A.7.4. DIALAB GmbH7.5. EKF Diagnostics Holdings PLC7.6. F. Hoffmann-La Roche Ltd.7.7. Fujifilm Holdings Corp.7.8. General Electric Co.7.9. GenMark Diagnostics, Inc.7.10. Hologic, Inc.7.11. Koninklijke Philips N.V.7.12. Luminex Corp.7.13. Nova Biomedical Pte. Ltd.7.14. PerkinElmer Inc.7.15. QIAGEN N.V.7.16. Quest Diagnostics Inc.7.17. Siemens AG7.18. Somagen Diagnostics Inc.7.19. Thermo Fisher Scientific Inc.7.20. Trinity Biotech PLC For more information about this report visit
Research and Markets also offers services providing focused, comprehensive and tailored research.
Laura Wood, Senior Press Manager
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Globe Newswire: 12:33 GMT Tuesday 14th January 2020
SPi News is published by Sector Publishing Intelligence Ltd.
© Sector Publishing Intelligence Ltd 2020. [Admin Only]
Sector Publishing Intelligence Ltd.
Agriculture House, Acland Road, DORCHESTER, Dorset DT1 1EF United Kingdom
Registered in England and Wales number 07519380.